Diamyd Medical AB (publ) reported earnings results for the first quarter ended November 30, 2016. For the quarter, the company reported net income of SEK 437,000 against SEK 190,000 a year ago. Total operating income was SEK 452,000 against SEK 246,000 a year ago. Operating loss was SEK 4,445,000 against SEK 4,309,000 a year ago. Loss before taxes and net loss was SEK 4,336,000 against SEK 4,302,000 a year ago. Net cash used in operating activities was SEK 4,653,000 against SEK 4,844,000 a year ago. Investment in financial assets was SEK 427,000.